A retrospective case-control study at a tertiary pediatric hospital reviewed 680 children (and 1828 clinic visits) followed for IH, of whom 216 were treated with propranolol.
Incidence of respiratory episodes was noted in treatment and control groups.
Propranolol does not appear to exacerbate wheezing episodes in IH infants and children.
Published on: 03/07/2017
"Propranolol is the treatment of choice for infantile haemangiomas requiring medical intervention". Contraindicated in asthmatic children because of its bronchoconstrictive effects, its effects on wheezing episodes in infants and children treated with propranolol for IH has not been extensively studied.